Proof of Principle: Phase I - Spring 2009 Priority Announcement (Cancer Research in Early Detection, Imaging and/or Translational Therapeutics) – Funding Decisions Notification (April 2009 Competition: 200904PCA)

(Alternate Title: Proof of Principle Program Phase I - Cancer Research)

The Canadian Institutes of Health Research (CIHR) is pleased to announce the results of the Proof of Principle: Phase I - Spring 2009 Priority Announcement (Cancer Research in Early Detection, Imaging and/or Translational Therapeutics) competition.

Funding Opportunity Summary

The objectives of the funding opportunity "Proof of Principle: Phase I - Spring 2009 Priority Announcement (Cancer Research in Early Detection, Imaging and/or Translational Therapeutics)" were to:

  • Early Detection: this includes, but is not limited to:
    • new or improved cancer screening technologies to detect early stage malignant or pre-malignant lesions
    • molecular genetic tests for predicting cancer risk
    • biomarker-based screening technologies
    • new or improved cancer screening technologies that are safer, or offer increased sensitivity and specificity over current methods 
  • Imaging: this includes, but is not limited to:
    • novel or improved imaging and spectroscopic technologies for early detection, screening, diagnosis and image-guided treatment of cancer
  • Translational Therapeutics: the development of cancer therapeutics which includes, but is not limited to:
    • small molecule therapeutics for validated cancer targets
    • biologicals aimed against a validated cancer target or cancer cells
    • devices for cancer therapy

Funding Competition Summary

A total of 7 applications were received of which 2 were approved for funding.

Contact Information

For further information about this competition, please contact:

Edit Palencsar
Program Delivery Coordinator
Canadian Institutes of Health Research
Telephone: 613-946-0095
Fax: 613-954-1800
Email: edit.palencsar@cihr-irsc.gc.ca

For further information about this initiative and the objectives of this funding opportunity please contact:

David Hartell
Associate, Institute Strategic Initiatives
CIHR Institute of Cancer Research
Telephone: 613-941-4329
Fax: 613-954-1800
E-mail: david.hartell@cihr-irsc.gc.ca

Funding Decisions Data Report

Access the "Proof of Principle Program Phase I - Cancer Research" funding decisions data report.